Our systems‐level analysis of the brain proteome offers new insights into the pathways and cell types underlying clinical phenotypes across the ALS‐FTD spectrum and provides evidence that the C9orf72 mutation is associated with neuroinflammation in brain. Here, C9orf72 is linked to amyotrophic lateral sclerosis.